Labcorp Holdings Past Earnings Performance
Past criteria checks 0/6
Labcorp Holdings's earnings have been declining at an average annual rate of -1.7%, while the Healthcare industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 1.1% per year. Labcorp Holdings's return on equity is 5%, and it has net margins of 3.2%.
Key information
-1.7%
Earnings growth rate
-0.1%
EPS growth rate
Healthcare Industry Growth | 8.5% |
Revenue growth rate | 1.1% |
Return on equity | 5.0% |
Net Margin | 3.2% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
When Should You Buy Labcorp Holdings Inc. (NYSE:LH)?
Jun 13Here's Why It's Unlikely That Laboratory Corporation of America Holdings' (NYSE:LH) CEO Will See A Pay Rise This Year
May 08Laboratory Corporation of America Holdings (NYSE:LH) Is Paying Out A Dividend Of $0.72
Apr 30Laboratory Corporation of America Holdings (NYSE:LH) Is Due To Pay A Dividend Of $0.72
Apr 15Laboratory Corporation of America Holdings' (NYSE:LH) P/E Is On The Mark
Apr 06Laboratory Corporation: A Healthier Diagnosis, As Pandemic Headwinds Disappear
Apr 01Laboratory Corporation of America Holdings (NYSE:LH) Will Pay A Dividend Of $0.72
Feb 25We Think You Can Look Beyond Laboratory Corporation of America Holdings' (NYSE:LH) Lackluster Earnings
Feb 22An Intrinsic Calculation For Laboratory Corporation of America Holdings (NYSE:LH) Suggests It's 48% Undervalued
Feb 21Laboratory Corporation of America Holdings (NYSE:LH) Has Affirmed Its Dividend Of $0.72
Jan 31Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 30Laboratory Corporation of America Holdings' (NYSE:LH) Dividend Will Be $0.72
Jan 15Some Shareholders Feeling Restless Over Laboratory Corporation of America Holdings' (NYSE:LH) P/E Ratio
Jan 05Laboratory Corporation: Multiple Updates, Same Investment Conclusion
Dec 02Laboratory Corp.: Rate On Capital Deployed Contracting, Hold
Sep 14Laboratory Corporation: Trying To Create Value By Spinning Out Fortrea
Jul 05Newsflash: Laboratory Corporation of America Holdings (NYSE:LH) Analysts Have Been Trimming Their Revenue Forecasts
Jul 04Are Investors Undervaluing Laboratory Corporation of America Holdings (NYSE:LH) By 43%?
Jun 23Laboratory Corporation: Predictability Of Cash Flows Less Visible
Jun 21Is It Too Late To Consider Buying Laboratory Corporation of America Holdings (NYSE:LH)?
May 26Laboratory Corporation of America Holdings' (NYSE:LH) Returns On Capital Are Heading Higher
Mar 16Laboratory Corporation of America Holdings (NYSE:LH) Shares Could Be 32% Below Their Intrinsic Value Estimate
Mar 02Laboratory Corporation of America Non-GAAP EPS of $4.14 in-line, revenue of $3.7B misses by $40M, introduces FY23 outlook
Feb 16At US$254, Is It Time To Put Laboratory Corporation of America Holdings (NYSE:LH) On Your Watch List?
Jan 30Laboratory Corporation: Plenty Of Growth Runway
Jan 19Here's Why Laboratory Corporation of America Holdings (NYSE:LH) Can Manage Its Debt Responsibly
Jan 16Laboratory Corporation of America declares $0.72 dividend
Jan 12Returns At Laboratory Corporation of America Holdings (NYSE:LH) Are On The Way Up
Dec 07Is There An Opportunity With Laboratory Corporation of America Holdings' (NYSE:LH) 25% Undervaluation?
Nov 24Laboratory Corporation: Buy Rating Holds Following Solid Mid-Level Growth
Nov 08Laboratory Corporation of America Q3 2022 Earnings Preview
Oct 26Revenue & Expenses Breakdown
How Labcorp Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 12,300 | 399 | 2,084 | 0 |
31 Dec 23 | 12,162 | 379 | 2,032 | 0 |
30 Sep 23 | 12,058 | 583 | 1,944 | 0 |
30 Jun 23 | 11,868 | 677 | 1,872 | 0 |
31 Mar 23 | 11,757 | 789 | 1,798 | 0 |
31 Dec 22 | 11,864 | 1,002 | 1,763 | 0 |
30 Sep 22 | 12,990 | 1,518 | 1,851 | 0 |
30 Jun 22 | 14,186 | 1,829 | 1,918 | 0 |
31 Mar 22 | 15,104 | 2,028 | 1,944 | 0 |
31 Dec 21 | 13,136 | 2,195 | 1,690 | 0 |
30 Sep 21 | 16,555 | 2,763 | 1,894 | 0 |
30 Jun 21 | 16,388 | 2,879 | 1,787 | 0 |
31 Mar 21 | 15,316 | 2,643 | 1,718 | 0 |
31 Dec 20 | 13,979 | 1,556 | 1,729 | 0 |
30 Sep 20 | 12,442 | 845 | 1,550 | 0 |
30 Jun 20 | 11,475 | 362 | 1,535 | 0 |
31 Mar 20 | 11,587 | 321 | 1,523 | 0 |
31 Dec 19 | 11,555 | 824 | 1,625 | 0 |
30 Sep 19 | 11,389 | 755 | 1,521 | 0 |
30 Jun 19 | 11,292 | 853 | 1,496 | 0 |
31 Mar 19 | 11,276 | 896 | 1,490 | 0 |
31 Dec 18 | 11,333 | 884 | 1,578 | 0 |
30 Sep 18 | 11,291 | 1,414 | 1,504 | 0 |
30 Jun 18 | 11,081 | 1,266 | 1,483 | 0 |
31 Mar 18 | 10,743 | 1,217 | 1,458 | 0 |
31 Dec 17 | 10,308 | 1,227 | 1,499 | 0 |
30 Sep 17 | 9,951 | 724 | 1,436 | 0 |
30 Jun 17 | 9,702 | 732 | 1,471 | 0 |
31 Mar 17 | 9,556 | 751 | 1,522 | 0 |
31 Dec 16 | 9,553 | 712 | 1,306 | 0 |
30 Sep 16 | 9,295 | 658 | 1,592 | 0 |
30 Jun 16 | 9,192 | 633 | 1,652 | 0 |
31 Mar 16 | 9,029 | 599 | 1,556 | 0 |
31 Dec 15 | 8,506 | 438 | 1,469 | 0 |
30 Sep 15 | 7,774 | 447 | 1,360 | 0 |
30 Jun 15 | 7,056 | 430 | 1,213 | 0 |
31 Mar 15 | 6,353 | 401 | 1,204 | 0 |
31 Dec 14 | 6,012 | 511 | 1,181 | 0 |
30 Sep 14 | 5,936 | 518 | 1,164 | 0 |
30 Jun 14 | 5,846 | 529 | 1,143 | 0 |
31 Mar 14 | 5,798 | 540 | 1,131 | 0 |
31 Dec 13 | 5,808 | 574 | 1,129 | 0 |
30 Sep 13 | 5,777 | 568 | 1,122 | 0 |
30 Jun 13 | 5,734 | 567 | 1,118 | 0 |
Quality Earnings: LH has a large one-off loss of $464.2M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: LH's current net profit margins (3.2%) are lower than last year (6.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LH's earnings have declined by 1.7% per year over the past 5 years.
Accelerating Growth: LH's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: LH had negative earnings growth (-49.4%) over the past year, making it difficult to compare to the Healthcare industry average (15.1%).
Return on Equity
High ROE: LH's Return on Equity (5%) is considered low.